GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » EV-to-Revenue

Notable Labs (Notable Labs) EV-to-Revenue : (As of May. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Notable Labs's enterprise value is $1.50 Mil. Notable Labs does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Notable Labs's EV-to-Revenue at this moment.

The historical rank and industry rank for Notable Labs's EV-to-Revenue or its related term are showing as below:

NTBL' s EV-to-Revenue Range Over the Past 10 Years
Min: -21.41   Med: -15.18   Max: 4427.2
Current: 4.83

During the past 3 years, the highest EV-to-Revenue of Notable Labs was 4427.20. The lowest was -21.41. And the median was -15.18.

NTBL's EV-to-Revenue is ranked worse than
57.75% of 1039 companies
in the Biotechnology industry
Industry Median: 8.37 vs NTBL: 4.83

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), Notable Labs's stock price is $1.25. Notable Labs does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Notable Labs's PS Ratio at this moment.

Notable Labs EV-to-Revenue Historical Data

The historical data trend for Notable Labs's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs EV-to-Revenue Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
EV-to-Revenue
- - 23.45

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
EV-to-Revenue - - 23.45

Competitive Comparison of Notable Labs's EV-to-Revenue

For the Biotechnology subindustry, Notable Labs's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Notable Labs's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Notable Labs's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Notable Labs's EV-to-Revenue falls into.


Notable Labs EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Notable Labs's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1.497/
=

Notable Labs  (NAS:NTBL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Notable Labs's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.25/
=

Notable Labs EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Notable Labs's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs (Notable Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » EV-to-Revenue
Comparable Companies
NLSP ACST AGE CRBP NBIO CLRB AIM PLUR BIXT SNSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Website
https://notablelabs.com
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.